(Q37045219)

17 August 2017

1 reference

title

Nephrogenic systemic fibrosis: a review and exploration of the role of gadolinium (English)

1 reference

nephrogenic systemic fibrosis

17 August 2017

0 references

1 reference

Shawn E Cowper

1

1 reference

PubMed ID

18159899

17 August 2017

language of work or name

1 reference

1 January 2007

1 reference

17 August 2017

Advances in dermatology

1 reference

17 August 2017

23

1 reference

17 August 2017

131-154

1 reference

What nephrogenic fibrosing dermopathy might be

17 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Scleromyxoedema-like cutaneous diseases in renal-dialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Nephrogenic fibrosing dermopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Nephrogenic fibrosing dermopathy (scleromyxedema-like illness of renal disease).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Nephrogenic fibrosing dermopathy: a novel cutaneous fibrosing disorder in patients with renal failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Nephrogenic fibrosing dermopathy in two patients with systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Nephrogenic systemic fibrosis: the nosological and conceptual evolution of nephrogenic fibrosing dermopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Successful treatment of three cases of nephrogenic fibrosing dermopathy with extracorporeal photopheresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Osseous metaplasia in the setting of nephrogenic fibrosing dermopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Nephrogenic Systemic Fibrosis: Suspected Causative Role of Gadodiamide Used for Contrast-Enhanced Magnetic Resonance Imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Nephrogenic systemic fibrosis: a review of 6 cases temporally related to gadodiamide injection (omniscan).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Nephrogenic fibrosing dermopathy: the first 6 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Nephrogenic fibrosing dermopathy: a series in a non-Western population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Nephrogenic systemic fibrosis: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Clinical and pathologic features of nephrogenic fibrosing dermopathy: a report of two cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Nephrogenic fibrosing dermopathy: suspect identified, motive unclear

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Nephrogenic fibrosing dermopathy after liver transplantation successfully treated with plasmapheresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Nephrogenic systemic fibrosis: an emerging threat among renal patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Scleromyxedema-like fibromucinosis in a patient undergoing hemodialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Scleromyxoedema-like changes in four renal dialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis with diaphragmatic involvement in a patient with respiratory failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis--setting the record straight

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Nephrogenic fibrosing dermopathy with systemic involvement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): study of inflammatory cells and transforming growth factor beta1 expression in affected skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Presence of CD45RO+ CD34+ cells with collagen synthesis activity in nephrogenic fibrosing dermopathy: a new pathogenic hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Interference of gadodiamide injection (OMNISCAN) on the colorimetric determination of serum calcium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Histopathologic comparison of nephrogenic fibrosing dermopathy and scleromyxedema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Nephrogenic fibrosing dermopathy: a novel, disabling disorder in patients with renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Two patients with abnormal skeletal muscle uptake of Tc-99m hydroxymethylene diphosphonate following liver transplant: nephrogenic fibrosing dermopathy and graft vs host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Involvement of skeletal muscle in dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Gadolinium deposition in nephrogenic fibrosing dermopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

A cytokine reborn? Endothelin-1 in pulmonary inflammation and fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

A pediatric case of nephrogenic fibrosing dermopathy: improvement after combination therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

UV-A1 phototherapy improves nephrogenic fibrosing dermopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Nephrogenic Systemic Fibrosis: A Mysterious Disease in Patients with Renal Failure--Role of Gadolinium-Based Contrast Media in Causation and the Beneficial Effect of Intravenous Sodium Thiosulfate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Peripheral blood fibrocytes: differentiation pathway and migration to wound sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

The role of circulating fibrocytes in fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

The endothelin system and its antagonism in chronic kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Signalling and regulation of collagen I synthesis by ET-1 and TGF-beta1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Impairment of skin microvascular reactivity in hypertension and uraemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Endothelin-1 and neutrophil activation during heparin-coated cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

Safety of Gadolinium Contrast Agent in Hemodialysis Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.002

10.1016/J.YADR.2007.07.002

7 January 2021

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

18159899